Leatt Corp
OTC:LEAT

Watchlist Manager
Leatt Corp Logo
Leatt Corp
OTC:LEAT
Watchlist
Price: 9.26 USD 0.22% Market Closed
Market Cap: $57.8m

Leatt Corp
Investor Relations

Leatt Corp. engages in the design, development, marketing, and distribution of personal protective equipment. The firm sells its products to customers across the world, through a network of distributors and retailers. The company also acts as the original equipment manufacturer for neck braces sold by other international brands. The firm's products are based on the Leatt-Brace system, an injection molded neck protection system, designed to prevent devastating injuries to the cervical spine and neck. The firm's products include Leatt-Brace, Leatt Helmet Range and Leatt Body Armor Range. The firm also sells clothing and outerwear. Its hydration systems include Hydration Ultra 750 HF and Hydration Pack GPX Race HF 2.0.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Mar 24, 2026
AI Summary
Q4 2025

Revenue: Total 2025 revenue was $61.91 million, up 41% year‑over‑year; Q4 revenue was $16.0 million, up 43% YoY.

Profitability: Full‑year net income was $3.26 million (vs. a loss in 2024); Q4 net income was $465,000 and gross margin expanded to 46% in the quarter (44% for the year).

Product momentum: Broad-based growth — helmets +59%, body armor +29%, other parts & accessories +56%, neck braces +18% — driven by higher volumes and new product rollouts.

Channels & regions: International revenue $44.64 million (up 47%); customer‑direct sales +44% and U.S. dealer sales +22% as the domestic sales team was rebuilt.

Capital & liquidity: Cash, cash equivalents and restricted cash totaled $13.23 million at year‑end; Board extended share repurchase authorization up to $750,000 (through March 31, 2026).

Headwinds & costs: Management cited tariff uncertainty as a modest headwind; operating costs rose 12% and working capital investments are expected to grow to support channel expansion.

Outlook: Management is optimistic, plans continued investment in marketing/sales and new products (notable focus on ADV market) and believes liquidity is sufficient to fund growth.

Key Financials
Total revenues (full year)
$61.91 million
Total revenues (Q4)
$16.0 million
International revenues (full year)
$44.64 million
Net income (full year)
$3.26 million
Net income (Q4)
$465,000
Earnings per share (full year) - basic
$0.53
Earnings per share (full year) - diluted
$0.51
Earnings per share (Q4) - basic
$0.07
Earnings per share (Q4) - diluted
$0.07
Gross profit as % of sales (Q4)
46%
Gross profit as % of sales (full year)
44%
Income before tax (full year)
$4.41 million
Cash, cash equivalents and restricted cash
$13.23 million
Current ratio
4.9
Operating costs
increased 12%
Neck brace revenues (full year)
$2.89 million
Body armor revenues (full year)
$28.98 million
Helmet revenues (full year)
$13.31 million
Other products, parts & accessories (full year)
$16.73 million
Share repurchase authorization
up to $750,000
Earnings Call Recording
Other Earnings Calls

Management

Dr. Christopher James Leatt ChB, MB
Founder, Chairman, R&D Consultant and Innovation Officer
No Bio Available
Mr. Sean MacDonald C.A., CA (SA)
CEO, CFO, President & Director
No Bio Available
Mr. Michael Mason J.D.
Investor Relations
No Bio Available
Lara-Jane Pretorius
Chief Legal & Compliance Officer and Corporate Secretary
No Bio Available
Mr. Erik Olsson
International GM & Head of International Distribution
No Bio Available

Contacts

Address
WESTERN CAPE
12 Kiepersol Drive, Atlas Gardens, Contermanskloof Road
Contacts
+27215565409.0
leatt-corp.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett